BRD2 and acute lymphoblastic leukemia: Of the 12 markers investigated, eight of them (rs1142345, rs1800460, rs1800909, rs1801133, rs2306283, rs3758149, rs4149056 and rs9344) did not show statistically significant differences between traditional Amerindian populations (NAT) and patients with ALL (ALL_NAT).